United States Biotechnology & Medical Research

Axcella Health Inc (AXLA)

Track

Ticker: AXLA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Axcella Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Mar 2023
Value US$4,702,914.87 | Price 349.53 | Shares 6,861 (-4.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-03 2023-03-01 PlS Planned sale
Koziel Margaret

Chief Medical Officer

Officer
6,861 -4.3%
349.53
US$4,702,915 		6,861 -4.3% 349.53 US$4,702,915
2022-10-19 2022-10-19 S Sale
2.9
Hinshaw William

President & CEO

Executive Director
9,883 -36.8%
170.39
US$2,211,678 		9,883 -36.8% 170.39 US$2,211,678
2022-10-17 2022-10-13 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
93,455 +14.5%
162.43
US$4,127,535 		93,455 +14.5% 162.43 US$4,127,535
2022-10-17 2022-10-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
3,048,780 +inf%
1.64
US$4,999,999 		3,048,780 +inf% 1.64 US$4,999,999
2022-10-17 2022-10-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
919,111 +17.1%
1.64
US$1,507,342 		919,111 +17.1% 1.64 US$1,507,342
2022-10-17 2022-10-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
914,634 +20.5%
1.64
US$1,500,000 		914,634 +20.5% 1.64 US$1,500,000
2022-10-17 2022-10-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
2,757,333 +24.3%
1.64
US$4,522,026 		2,757,333 +24.3% 1.64 US$4,522,026
2022-10-17 2022-10-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
2,743,902 +31.9%
1.64
US$4,499,999 		2,743,902 +31.9% 1.64 US$4,499,999
2022-09-08 2022-09-06 S Sale
Koziel Margaret

Chief Medical Officer

Officer
547 -2.1%
2.52
US$1,378 		547 -2.1% 2.52 US$1,378
2022-06-02 2022-06-01 S Sale
Koziel Margaret

Chief Medical Officer

Officer
590 -2.2%
2.01
US$1,186 		590 -2.2% 2.01 US$1,186
2022-03-18 2022-03-16 B Purchase
2.1
Epstein David R
Non-Executive Director
26,178 +19.4%
1.91
US$50,000 		26,178 +19.4% 1.91 US$50,000
2022-03-18 2022-03-16 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
1,579,843 +54.7%
1.91
US$3,017,500 		1,579,843 +54.7% 1.91 US$3,017,500
2022-03-18 2022-03-16 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
947,905 +89.7%
1.91
US$1,810,499 		947,905 +89.7% 1.91 US$1,810,499
2022-03-18 2022-03-16 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
3,791,623 +78.8%
1.91
US$7,242,000 		3,791,623 +78.8% 1.91 US$7,242,000
2022-03-18 2022-03-16 B Purchase
2.9
Fehlner Paul

SVP & Chief Legal Officer

Officer
10,471 +101.4%
1.91
US$20,000 		10,471 +101.4% 1.91 US$20,000
2022-03-18 2022-03-16 B Purchase
2.9
Crane Robert

Chief Financial Officer

Officer
39,267 +inf%
1.91
US$75,000 		39,267 +inf% 1.91 US$75,000
2022-03-18 2022-03-16 B Purchase
2.9
Hinshaw William

President & CEO

Executive Director
13,089 +37.5%
1.91
US$25,000 		13,089 +37.5% 1.91 US$25,000
2022-03-16 2022-03-16 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
3,141,361 +73.0%
1.91
US$6,000,000 		3,141,361 +73.0% 1.91 US$6,000,000
2022-03-03 2022-03-01 S Sale
Koziel Margaret

Chief Medical Officer

Officer
553 -2.0%
1.86
US$1,030 		553 -2.0% 1.86 US$1,030
2022-02-01 2022-01-31 S Sale
2.9
Hinshaw William

President and CEO

Executive Director
16,590 -33.2%
1.65
US$27,393 		16,590 -33.2% 1.65 US$27,393
2021-02-03 2021-02-01 S Sale
Chakravarthy Manu

SVP & Chief Medical Officer

Officer
18,472 -30.8%
5.50
US$101,631 		18,472 -30.8% 5.50 US$101,631
2020-05-21 2020-05-18 B Purchase
Nestle Health Science US Holdings, Inc.
Large shareholder
1,936,842 +81.8%
4.75
US$9,200,000 		1,936,842 +81.8% 4.75 US$9,200,000
2020-05-20 2020-05-18 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
1,900,000 +192.7%
4.75
US$9,025,000 		1,900,000 +192.7% 4.75 US$9,025,000
2020-05-20 2020-05-18 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
380,000 +56.2%
4.75
US$1,805,000 		380,000 +56.2% 4.75 US$1,805,000
2020-05-20 2020-05-18 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
1,520,000 +46.2%
4.75
US$7,220,000 		1,520,000 +46.2% 4.75 US$7,220,000
2020-05-20 2020-05-18 B Purchase
2.1
Epstein David R
Non-Executive Director
50,000 +73.4%
4.75
US$237,500 		50,000 +73.4% 4.75 US$237,500
2020-03-02 2020-02-28 B Purchase
2.1
Epstein David R
Non-Executive Director
2,005 +3.0%
3.75
US$7,519 		2,005 +3.0% 3.75 US$7,519
2020-03-02 2020-02-27 B Purchase
2.1
Epstein David R
Non-Executive Director
12,800 +24.0%
3.65
US$46,720 		12,800 +24.0% 3.65 US$46,720
2020-01-31 2020-01-31 B Purchase
3.6
Chardonnet Laurent

Chief Financial Officer
3,000 +451.1%
4.94
US$14,820 		3,000 +451.1% 4.94 US$14,820
2020-01-28 2020-01-27 B Purchase
3.6
Chardonnet Laurent

Chief Financial Officer
352 +112.5%
4.94
US$1,739 		352 +112.5% 4.94 US$1,739
2020-01-28 2020-01-24 B Purchase
3.6
Chardonnet Laurent

Chief Financial Officer
313 +inf%
4.92
US$1,540 		313 +inf% 4.92 US$1,540
2020-01-21 2020-01-17 B Purchase
3.2
Sohn Catherine A.
1,000 +inf%
4.87
US$4,870 		1,000 +inf% 4.87 US$4,870
2019-12-03 2019-11-27 B Purchase Epstein David R Non-Executive Director
1,005 +1.9%
3.91
US$3,930 		1,005 +1.9% 3.91 US$3,930
2019-12-02 2019-11-27 B Purchase Epstein David R Non-Executive Director
1,005 +1.9%
3.91
US$3,930 		1,005 +1.9% 3.91 US$3,930
2019-12-03 2019-11-26 B Purchase Epstein David R Non-Executive Director
14,000 +36.6%
3.55
US$49,700 		14,000 +36.6% 3.55 US$49,700
2019-12-02 2019-11-26 B Purchase Epstein David R Non-Executive Director
14,000 +36.6%
3.55
US$49,700 		14,000 +36.6% 3.55 US$49,700
2019-08-05 2019-08-02 B Purchase Epstein David R Non-Executive Director
2,849 +8.0%
7.04
US$20,057 		2,849 +8.0% 7.04 US$20,057
2019-08-05 2019-08-01 B Purchase Epstein David R Non-Executive Director
4,092 +13.1%
6.98
US$28,562 		4,092 +13.1% 6.98 US$28,562
2019-07-18 2019-07-17 B Purchase
2.1
Epstein David R
1,000 +3.3%
7.55
US$7,550 		1,000 +3.3% 7.55 US$7,550
2019-07-10 2019-07-10 B Purchase
2.1
Epstein David R
1,322 +4.6%
8.07
US$10,669 		1,322 +4.6% 8.07 US$10,669
2019-07-10 2019-07-09 B Purchase
2.1
Epstein David R
4,200 +16.9%
8.24
US$34,608 		4,200 +16.9% 8.24 US$34,608
2019-07-10 2019-07-08 B Purchase
2.1
Epstein David R
274 +1.1%
9.00
US$2,466 		274 +1.1% 9.00 US$2,466
2019-07-03 2019-07-03 B Purchase
2.1
Epstein David R
56 +0.3%
8.99
US$503 		56 +0.3% 8.99 US$503
2019-07-03 2019-07-02 B Purchase
2.1
Epstein David R
3,500 +22.6%
8.77
US$30,678 		3,500 +22.6% 8.77 US$30,678
2019-07-03 2019-07-01 B Purchase
2.1
Epstein David R
1,000 +6.9%
8.74
US$8,735 		1,000 +6.9% 8.74 US$8,735
2019-07-01 2019-06-28 B Purchase
2.1
Epstein David R
5,400 +37.0%
10.04
US$54,216 		5,400 +37.0% 10.04 US$54,216
2019-07-01 2019-06-27 B Purchase
2.1
Epstein David R
100 +0.7%
9.15
US$915 		100 +0.7% 9.15 US$915
2019-06-27 2019-06-26 B Purchase
2.1
Epstein David R
14,500 +inf%
9.57
US$138,765 		14,500 +inf% 9.57 US$138,765
2019-05-15 2019-05-13 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
500,000 +102.9%
20.00
US$10,000,000 		500,000 +102.9% 20.00 US$10,000,000
Explore more

More insider trading research around Axcella Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America